|
|
Post by sportsrancho on Nov 12, 2019 15:22:35 GMT -5
By Harry
$MNKD Less than 30 days til the anniversary of the Xmas massacre, just so you know, I gave Mike an earful a day after that announcement & told him that I hoped that it wasn't done to make sure management got their raises & bonuses & hoped that it was going to be used wisely. I also stated on STs that he should've put his entire bonus into buying MNKD stock but he never did. The stock price has been mostly near a $1 for 3 years now, it's a public company so a CEO is measured partly by the performance of the company's stock price/market cap. I'm saying it now, there better be no raises or bonuses this year & there most certainly should not be another raise of money through dilution after those warrants expire. My shares have been pledged to only me, no one else or any other organization. It's absolutely ridiculous that we are still sitting near a $1 or $250M market cap. We should be at least near $1B market cap. Just needed to get that off my chest. Get the pipeline moving ASAP!!
Business days, yes I know what Mike is doing, it's not an easy job but this company doesn't need a conventional CEO. It's needs to move at a faster pace on solutions, the pipeline (at least a few molecules) should be further along that it is. He messed up big time with that Xmas massacre, it should've never happened and although it did happen, should have tried to right it other ways IMO.
Keeportrade... Well said and yes, thank you for all you do. IMO, this should be the post of the year.
|
|
|
|
Post by slugworth008 on Nov 12, 2019 17:54:42 GMT -5
By Harry $MNKD Less than 30 days til the anniversary of the Xmas massacre, just so you know, I gave Mike an earful a day after that announcement & told him that I hoped that it wasn't done to make sure management got their raises & bonuses & hoped that it was going to be used wisely. I also stated on STs that he should've put his entire bonus into buying MNKD stock but he never did. The stock price has been mostly near a $1 for 3 years now, it's a public company so a CEO is measured partly by the performance of the company's stock price/market cap. I'm saying it now, there better be no raises or bonuses this year & there most certainly should not be another raise of money through dilution after those warrants expire. My shares have been pledged to only me, no one else or any other organization. It's absolutely ridiculous that we are still sitting near a $1 or $250M market cap. We should be at least near $1B market cap. Just needed to get that off my chest. Get the pipeline moving ASAP!! Business days, yes I know what Mike is doing, it's not an easy job but this company doesn't need a conventional CEO. It's needs to move at a faster pace on solutions, the pipeline (at least a few molecules) should be further along that it is. He messed up big time with that Xmas massacre, it should've never happened and although it did happen, should have tried to right it other ways IMO. Keeportrade... Well said and yes, thank you for all you do. IMO, this should be the post of the year. Absolutely Agree! - to bolt onto the above - I believe that Mango had a good post about MC taking the job initially- had no downside risk to his career. However, at this point I believe it absolutely does. If he doesn't unlock shareholder value with Afrezza and Technosphere - He'll be considered a failed CEO. JMHO |
|
bkdmd
Researcher
Posts: 79
|
Post by bkdmd on Nov 12, 2019 18:33:17 GMT -5
I feel betrayed by MC. He is already the poster child of what is wrong with wall street CEO and politicians. No one is ever willing to accept responsibility or be held accountable.
""It is hard to imagine a more stupid or more dangerous way of making decisions than by putting those decisions in the hands of people who pay no price for being wrong.""
Thomas Sowell
MC has put himself ahead of us. He is tone def and his actions tell us what he really thinks of us.
|
|
|
|
Post by lennymnkd on Nov 12, 2019 18:48:31 GMT -5
Don’t be so hard on the beaver, never know what the bev has up his sleeve ... remember even Al said all it takes is money .. not the case for us / if mike had the funds he would look like a hero .. we’re a small cap , not an easy task without giving away the ship.
|
|
|
|
Post by buyitonsale on Nov 12, 2019 19:30:37 GMT -5
Not easy to work on delivering value with balance sheet CEO inherited.
Recap is when clock really starts.
Everything until now has been about survival and laying a foundation for delivering value, which btw he accomplished.
Diabetes drug pushing cartel loses the war when the company makes profit and this is now within 24 months ...
|
|
|
|
Post by radgray68 on Nov 12, 2019 20:10:41 GMT -5
Man, you guys are really going to sh -- when they ask for another 100 Million shares next year. IMHO
I only want to soften the blow by mentioning it. If we want to get 40 molecules through to P1, we're going to need more cash. I think it's coming.
|
|
|
|
Post by bones1026 on Nov 12, 2019 21:49:41 GMT -5
Man, you guys are really going to sh -- when they ask for another 100 Million shares next year. IMHO I only want to soften the blow by mentioning it. If we want to get 40 molecules through to P1, we're going to need more cash. I think it's coming. By when? |
|
|
|
Post by morfu on Nov 12, 2019 22:21:20 GMT -5
By Harry $MNKD Less than 30 days til the anniversary of the Xmas massacre, just so you know, I gave Mike an earful a day after that announcement & told him that I hoped that it wasn't done to make sure management got their raises & bonuses & hoped that it was going to be used wisely. I also stated on STs that he should've put his entire bonus into buying MNKD stock but he never did. The stock price has been mostly near a $1 for 3 years now, it's a public company so a CEO is measured partly by the performance of the company's stock price/market cap. I'm saying it now, there better be no raises or bonuses this year & there most certainly should not be another raise of money through dilution after those warrants expire. My shares have been pledged to only me, no one else or any other organization. It's absolutely ridiculous that we are still sitting near a $1 or $250M market cap. We should be at least near $1B market cap. Just needed to get that off my chest. Get the pipeline moving ASAP!! Business days, yes I know what Mike is doing, it's not an easy job but this company doesn't need a conventional CEO. It's needs to move at a faster pace on solutions, the pipeline (at least a few molecules) should be further along that it is. He messed up big time with that Xmas massacre, it should've never happened and although it did happen, should have tried to right it other ways IMO. Keeportrade... Well said and yes, thank you for all you do. IMO, this should be the post of the year. While I strongly agree that the 20% dilution last year was unnecessary, I dont understand how the management can be held responsible for the current share price or what they should do about it.. I do believe that this quarter will be green, thanks to that milestone payment, but the next quarter should see about 4mil loss (somewhere between 1-2 ct per share). Extrapolating from the increases in TRx and sale price, we should cross the green line some time next year and then get about 2-3 ct per share more each year from the adult Afrezza sales in USA. I guess it is likely that we will see continuous green numbers in the near future and maybe 10-20ct EPS within 5 years.
At that time we might be 10-20$ per share (or 2-7Bil$), but where is the rational for the $250M vs. $1B right now? Is there more to it than just a gut feeling?
|
|
|
|
Post by awesomo on Nov 12, 2019 22:39:07 GMT -5
How are you extrapolating this growth in U.S. Afrezza net revenue when Q2 was higher than Q3 despite of what the Symphony sales say?
|
|
|
|
Post by brotherm1 on Nov 12, 2019 22:40:58 GMT -5
Since you’ve taken the time to extrapolate to the green line and beyond, you’re more than welcome to post your extrapolation.
|
|
|
|
Post by agedhippie on Nov 12, 2019 22:54:07 GMT -5
... I do believe that this quarter will be green, thanks to that milestone payment, but the next quarter should see about 4mil loss (somewhere between 1-2 ct per share). Extrapolating from the increases in TRx and sale price, we should cross the green line some time next year and then get about 2-3 ct per share more each year from the adult Afrezza sales in USA. I guess it is likely that we will see continuous green numbers in the near future and maybe 10-20ct EPS within 5 years.
At that time we might be 10-20$ per share (or 2-7Bil$), but where is the rational for the $250M vs. $1B right now? Is there more to it than just a gut feeling? You probably want to go and have a look the 10Q. The table at the bottom of page 29 is what you want. Look at the line "Net revenue - commercial product sales" and bear in mind $0.7M of that was from Brazil which is going to cover them for a while. Now look at the table at the bottom of page 30 which takes the net revenue and subtracts the cost of goods. That end number is negative, Afrezza lost money last quarter. If you remove the Brazil sale from the net revenue Afrezza revenue was lower last quarter than the previous quarter. If Afrezza sales continue to grow at the current rates they are years away from crossing that green line. Remember, it was a loss and that was before we even factored in the $9.5M selling Afrezza cost (or General and Administrative costs come to that). |
|
|
|
Post by morfu on Nov 12, 2019 23:17:06 GMT -5
How are you extrapolating this growth in U.S. Afrezza net revenue when Q2 was higher than Q3 despite of what the Symphony sales say? We are in the middle of quarter 4 right now and it is shaping up to break any revenue record.. being more than 25% higher than your beloved quarter 2..
I18 II18 III18 IV18 I19 II19 III19
Afrezza net 3.4 3.8 4.4 5.7 5.0 6.1 6.4 (0.7 of which is Brazil)
liane´s table 6.5 8.4 10 11.5 12.2 13.2 13.3
Anet over table .52 .45 .44 .50 .45 .46 .43 (corrected by subtracting Brazil amount)
net loss -30.4 -22.7 -24.2 -9.7 -14.9 -12.4 -10.4(which includes a M3.4$ one time payment )
In the past two years we seem to increase the USA net revenue by about M1.8$ per year The green numbers are NOT years away! (this quarter will be green thx to the milestone payment)
Aww.. I was wrong.. assuming there is no income from Brazil or other sources, these numbers seem to say, we were short 7.7mil in III19 (not counting Brazil or the M3.4$ one time), So in IV19, this number will shrink to about M6$ (not counting the milestone payment) This should shrink to about M4$ loss per quarter in 2020, if the trend continues like in the last two years, meaning there is no other milestone payment, Brazil revenue or jump like in September. Hmm new extrapolation M20$ loss in 2020, M12$ loss in 2021 and M4$ in 2022.. unless one of the 3 is happening . . (and we will start the next quarter with about M8$ more than we ended III19)
|
|
|
|
Post by buyitonsale on Nov 13, 2019 0:18:42 GMT -5
"bear in mind" in 24 months all bears will be in a permanent hibernation  |
|
|
|
Post by morfu on Nov 13, 2019 8:29:10 GMT -5
"bear in mind" in 24 months all bears will be in a permanent hibernation yeah on a Caribbean island.. |
|
|
|
Post by castlerockchris on Nov 13, 2019 14:14:43 GMT -5
You all make me laugh and for that I am grateful, especially in light of the post-earnings call slide of -20% in our equity, which is making me cry, again. In a post several months back I said if I were on the board I would give MC and his crew until the end of the year to demonstrate they have things moving in the right direction (script count growth that isn't anemic and a couple of potential new molecules in the pipeline). If not I will vote my shares to not re-elect the entire board. Three years is more than enough time to turn around an organization the size of MNKD.
Hope is not a strategy, but change is!
|
|
